ClinicalTrials.Veeva

Menu

Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome (VARIOXY)

T

Toulouse University Hospital

Status

Not yet enrolling

Conditions

Cardiac Surgery
Extracorporeal Circulation

Treatments

Other: walking test
Other: Blood and tissue samples

Study type

Observational

Funder types

Other

Identifiers

NCT06840327
ID-RCB (Other Identifier)
RC31/24/0523

Details and patient eligibility

About

Observational, prospective, monocentric study conducted in the cardiac surgery department about biological markers to predict the short-term outcome of heart surgery patients.

Full description

At present, there are no biological markers to predict the short-term outcome of heart surgery patients. Redox balance, determined by the interaction between oxidants and reducers in tissues, is an essential parameter in the regulation of cellular functions. Cardiac surgery with extracorporeal circulation (CEC) induces major disturbances in this balance. In preliminary work, it was observed that the redox potential (Eg) varied with the introduction of CEC, and a persistent imbalance appeared to correlate with post-operative complications. It is believed that Eg potential could be a new biomarker of the post-operative outcome of major surgery.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients over 18 years of age Scheduled cardiac surgery patients undergoing bypass surgery with saphenous vein harvesting.

Patients able to understand the protocol; Patients able to express non-opposition to participating in the study Patients affiliated to a social security system or equivalent.

Exclusion criteria

Emergency surgery patients. Pregnant or breast-feeding women. Patients deprived of their freedom or under legal protective measures.

Trial design

120 participants in 1 patient group

Scheduled cardiac surgery patients
Description:
Scheduled cardiac surgery patients undergoing bypass surgery with saphenous vein harvesting.
Treatment:
Other: walking test
Other: Blood and tissue samples

Trial contacts and locations

0

Loading...

Central trial contact

François LABASTE, MD-PH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems